Share

PSC- DS COPDefence 21 - An Adaptive Interventional Clinical Investigation to Evaluate the Efficacy and Safety of PulmonYDEFENCE in supporting the prevention of exacerbations in Chronic Obstructive Pulmonary Disease (COPD) patients.

Project objectives

Primary objective

  • To evaluate the performance of PulmonYDEFENCE in reducing the risk of exacerbations.

Secondary objectives 

  • To evaluate the performance of PulmonYDEFENCE in reducing the risk of exacerbations by standard therapy.
  • To evaluate the performance of PulmonYDEFENCE in supporting the prevention of exacerbations.
  • To evaluate the performance of PolmonYDEFENCE in improving the health-related quality of life (HRQoL).
  • To evaluate the safety and tolerability of PulmonYDEFENCE. • To evaluate patient's satisfaction with PulmonYDEFENCE

Start and end date
November 2021 - 2024

Project Manager
Simone Scarlata - Principal Investigator

Coordinating institution of the project
Campus Bio Medico Polyclinic Foundation

Other Institutions involved
  • IRCCS San Raffaele Pisana, Rome

Funding source(s).
• SOFAR SpA
2023© Università Campus Bio-Medico di Roma, Via Álvaro del Portillo, 21 - 00128 Rome, Tel. +39 06.22541.1, Fax +39 06.22541.456, VAT number: 048 020 51 005, Fiscal Code: 97087620585
QUICK LINKS
L'Università Campus Bio-Medico di Roma promotes integrated teaching and research structures, pursuing the good of the person as the main aim of its activities.
magnifiercrossmenuchevron-downchevron-leftchevron-right